KR910009271A - 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료 - Google Patents

15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료 Download PDF

Info

Publication number
KR910009271A
KR910009271A KR1019900018961A KR900018961A KR910009271A KR 910009271 A KR910009271 A KR 910009271A KR 1019900018961 A KR1019900018961 A KR 1019900018961A KR 900018961 A KR900018961 A KR 900018961A KR 910009271 A KR910009271 A KR 910009271A
Authority
KR
South Korea
Prior art keywords
composition
compound
ketoprostaglandin
ketoprostaglandin compound
treatment
Prior art date
Application number
KR1019900018961A
Other languages
English (en)
Other versions
KR0153779B1 (ko
Inventor
류지 우에노
히로요시 오사마
Original Assignee
우에노 류조
가부시기가이샤 우에노세이야꾸오오요겡꾸쇼
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우에노 류조, 가부시기가이샤 우에노세이야꾸오오요겡꾸쇼 filed Critical 우에노 류조
Publication of KR910009271A publication Critical patent/KR910009271A/ko
Application granted granted Critical
Publication of KR0153779B1 publication Critical patent/KR0153779B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

15-케토프로스타글란딘 화합물을 약제학적으로 허용 가능한 담체, 희석제 또는 부형제와 함께 함유하는 폐 부전증 치료용 약제학적 조성물.
제1항에 있어서, 폐 부전증이 세포독소 저산소증 또는 호흡 곤란증에 기인하는 조성물.
제1항에 있어서, 상기 15-케토프로스타글란딘 화합물이 16-모노- 또는 디-할로-15-케토프로스타글란딘 화합물인 조성물.
제1항에 있어서, 상기 15-케토프로스타글란딘 화합물이 13,14-디히드로-16-모노- 또는 디-할로-15-케토프로스타글란딘 화합물인 조성물.
제1항에 있어서, 상기 15-케토프로스타글란딘 화합물이 13,14-디히드로-16-모노- 또는 디-플루오로-15-케토프로스타글란딘 화합물인 조성물.
제1항에 있어서, 상기 15-케토프로스타글란딘 화합물이 6,15-디케토프로스타글란딘 화합물인 조성물.
불충분한 가스 변화 기능을 치료하기 위한 제1항에 따른 조성물.
폐수종을 치료하기 위한 제1항에 따른 조성물.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900018961A 1989-11-22 1990-11-22 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료 KR0153779B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30384189 1989-11-22
JP1-303841 1989-11-22
JP303841/89 1989-11-22

Publications (2)

Publication Number Publication Date
KR910009271A true KR910009271A (ko) 1991-06-28
KR0153779B1 KR0153779B1 (ko) 1998-11-16

Family

ID=17925951

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900018961A KR0153779B1 (ko) 1989-11-22 1990-11-22 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료

Country Status (5)

Country Link
EP (1) EP0430552B1 (ko)
KR (1) KR0153779B1 (ko)
AT (1) ATE129895T1 (ko)
CA (1) CA2030344C (ko)
DE (1) DE69023459T2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ336960A (en) * 1997-11-28 2001-02-23 R Tech Ueno Ltd Use of 15-keto-prostaglandin E compounds for the preparation of medicaments for use as endothelin antagonists
PT1220849E (pt) * 1999-10-15 2004-10-29 Sucampo Ag Composicao de compostos biciclicos e metodo para a sua estabilizacao
AU2002330747B2 (en) 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
AR059636A1 (es) * 2006-02-28 2008-04-16 Sucampo Ag Metodo y composicion para tratar la enfermedad pulmonar obstructiva cronica
AU2010253720A1 (en) * 2009-05-27 2011-12-08 Osaka University Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
US8569279B2 (en) 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764699A (en) * 1971-12-02 1973-10-09 American Home Prod Methods for relieving bronchial spasm with prostaglandin-f{11 and derivatives
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
JPS58164512A (ja) 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS5973522A (ja) 1982-10-20 1984-04-25 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患治療剤
JPS58203911A (ja) 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
ES2051862T3 (es) 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.
DE69025787T2 (de) * 1989-04-04 1996-10-31 Beiersdorf Ag Mittel zur Atopieprophylaxe

Also Published As

Publication number Publication date
EP0430552B1 (en) 1995-11-08
CA2030344A1 (en) 1991-05-23
DE69023459D1 (de) 1995-12-14
CA2030344C (en) 2000-04-18
EP0430552A3 (en) 1992-07-01
ATE129895T1 (de) 1995-11-15
EP0430552A2 (en) 1991-06-05
KR0153779B1 (ko) 1998-11-16
DE69023459T2 (de) 1996-04-04

Similar Documents

Publication Publication Date Title
ES2180530T3 (es) Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica.
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
FI860842A0 (fi) Labdan-derivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK0675717T3 (da) Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
AU652778B2 (en) Treatment composition
ES2062292T3 (es) Un proceso para la preparacion del compuesto que tiene la estructura (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-in-3-ona.
KR910009271A (ko) 15-케토-프로스타글란딘 화합물을 이용한 폐 부전증의 치료
SE8600017D0 (sv) New compound
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
IL97855A0 (en) Bromide containing pharmaceutical compositions for treatment of psoriasis
DE3667913D1 (de) Entzuendungshemmende zusammensetzung.
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
KR910018028A (ko) 15- 데히드록시-16-옥소프로스타글란딘 화합물에 의한 생화학적 치료
ES2095479T3 (es) Procedimiento para la obtencion del 8,12-oxido-13,14,15,16-tetranorlabdano.
ATE22531T1 (de) Pharmazeutische zusammenstellung fuer induktion von cytoprotektion.
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
SE8802040D0 (sv) New use
KR910007524A (ko) 관상동맥 부전증 치료를 위한 약제 제조에 있어 카보티오아미드 1-옥사이드의 이용
JPS5247984A (en) Stabilization of elastase
IT1233376B (it) Composizione farmaceutica contenente n-acetil-cisteina e suo impiego

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090527

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee